Lusha Clinical Trial Info
The Lusha clinical trial is part of a clinical approach designed to document the effectiveness of Lusha’s approach for children with ADHD and their families. This work is carried out in collaboration with Lusha’s scientific committee, AP-HP, Montpellier University Hospital, and Grenoble University Hospital.
This page presents public information about the LUSHA study registered on ClinicalTrials.gov. It is not a study enrollment page and does not replace information provided by the research teams.
This wiki is informational only and does not replace advice from a qualified healthcare professional or official study coordinator.
Official Source and Status
Section titled “Official Source and Status”The public source record is: NCT07204873 - Evaluation of the LUSHA Digital Application for Children With ADHD - Feasibility Study.
The study is listed as Not yet recruiting and is expected to start in mid-2026.
What Is the Study For?
Section titled “What Is the Study For?”The study looks at how children with ADHD and their parents use the LUSHA app over 3 months. The primary objective is to assess adherence and use over 90 days.
Secondary objectives include:
- app use at 1, 2, and 3 months;
- quality of life and family impact;
- behavior reported by parents;
- quality of life reported by the child;
- adoption of Lusha features, such as validated routines, emotion-management modules, and parent modules.
Who Is It For?
Section titled “Who Is It For?”According to the public record, the study concerns children aged 7 to 12 who already have an ADHD diagnosis, are consulting in a participating center, and do not have an indication for immediate treatment changes. The family must have a smartphone compatible with the app.
The record also mentions non-opposition from both parents and the child when possible. Healthy volunteers are not included.
How Is the Study Designed?
Section titled “How Is the Study Designed?”This is a feasibility interventional study, without medication, placebo, or comparison group. All participants use the LUSHA app.
For 3 months, children and parents use the app and answer online surveys. The primary use measure is cumulative app use: more than 30 minutes per week on average over 90 days.
Where Does It Take Place?
Section titled “Where Does It Take Place?”The ClinicalTrials.gov record lists two sites in France:
- University Hospital, Grenoble;
- University Hospital, Montpellier.
The sponsor is University Hospital, Grenoble, with DYGIE listed as a collaborator. Estimated enrollment is 80 participants.
Which App Should Families Use?
Section titled “Which App Should Families Use?”For the clinical trial, families must use a specific version of the app: Lusha Essai clinique. The standard Lusha app is not configured for the research protocol, study follow-up, and participant pathway.
Official contacts and participating centers are listed in the Contacts and Locations section of the ClinicalTrials.gov record. For questions about participation, eligibility, or next steps, families should refer to those contacts or to the healthcare professionals following the child.
What This Does Not Mean
Section titled “What This Does Not Mean”This study does not mean that Lusha replaces usual ADHD care. It evaluates app use and explores potential impact through validated questionnaires. Results must be interpreted by the research teams and relevant professionals.
For participation, eligibility, or care decisions, families should always refer to the study team and healthcare professionals.